Low bleeding acceptance is associated with increased death risk in patients with atrial fibrillation on oral anticoagulation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Low bleeding acceptance is associated with increased death risk in patients with atrial fibrillation on oral anticoagulation ; day:19 ; month:8 ; year:2023 ; pages:1-9
Journal of thrombosis and thrombolysis ; (19.8.2023), 1-9
- Urheber
-
Rusin, Gabriela
Konieczyńska, Małgorzata
Natorska, Joanna
Malinowski, Krzysztof Piotr
Undas, Anetta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-023-02878-8
- URN
-
urn:nbn:de:101:1-2023110414442615478144
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rusin, Gabriela
- Konieczyńska, Małgorzata
- Natorska, Joanna
- Malinowski, Krzysztof Piotr
- Undas, Anetta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
Anticoagulation Therapy for Atrial Fibrillation
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Harnessing Risk Assessment for Thrombosis and Bleeding to Optimize Anticoagulation Strategy in Nonvalvular Atrial Fibrillation
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
Bleeding Issues in Women Under Oral Anticoagulation
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
Oral Anticoagulation Timing in Patients with Acute Ischaemic Stroke and Atrial Fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
Anticoagulation Therapy for Atrial Fibrillation
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Harnessing Risk Assessment for Thrombosis and Bleeding to Optimize Anticoagulation Strategy in Nonvalvular Atrial Fibrillation
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
Bleeding Issues in Women Under Oral Anticoagulation
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
Oral Anticoagulation Timing in Patients with Acute Ischaemic Stroke and Atrial Fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
Anticoagulation Therapy for Atrial Fibrillation
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Harnessing Risk Assessment for Thrombosis and Bleeding to Optimize Anticoagulation Strategy in Nonvalvular Atrial Fibrillation
Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
Bleeding Issues in Women Under Oral Anticoagulation
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
Oral Anticoagulation Timing in Patients with Acute Ischaemic Stroke and Atrial Fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes